Beyond LNP: Explore the Thermostable & Safe Drug Delivery System, ‘DegradaBALL’ – Safety & Tolerability in Phase I Clinical Trials

• Overview of DegradaBALL as next-generation drug delivery system (DDS) platform technology
• Explore how excellent human safety has been confirmed in Phase I clinical trials of siRNA and mRNA pipelines employing DegradaBALL
• Discuss DegradaBALL applications in cancer immunotherapy

Speakers:

Dal-Hee Min

Chief Technology Officer & Professor

Lemonex Bio & Seoul National University